0001209191-18-052464.txt : 20180927
0001209191-18-052464.hdr.sgml : 20180927
20180927165014
ACCESSION NUMBER: 0001209191-18-052464
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180926
FILED AS OF DATE: 20180927
DATE AS OF CHANGE: 20180927
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dentzer James E
CENTRAL INDEX KEY: 0001400977
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30347
FILM NUMBER: 181091527
MAIL ADDRESS:
STREET 1: C/O AMICUS THERAPEUTICS, INC.
STREET 2: 6 CEDAR BROOK DRIVE
CITY: CRANBURY
STATE: NJ
ZIP: 08512
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CURIS INC
CENTRAL INDEX KEY: 0001108205
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 043505116
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4 MAGUIRE ROAD
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 617-503-6500
MAIL ADDRESS:
STREET 1: 4 MAGUIRE ROAD
CITY: LEXINGTON
STATE: MA
ZIP: 02421
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-09-26
0
0001108205
CURIS INC
CRIS
0001400977
Dentzer James E
C/O CURIS, INC.
4 MAGUIRE ROAD
LEXINGTON
MA
02421
1
1
0
0
President & CEO
Employee stock option (right to buy)
1.62
2018-09-26
4
A
0
750000
0.00
A
2028-09-25
Common stock
750000
750000
D
This option vests as to 25% of the shares on September 26, 2019 and as to an additional 6.25% of the original shares each successive three month period through and until September 26, 2022.
William Steinkrauss,
Attorney-in-fact
2018-09-27